Dakota Gold Corp [DC] - Last Close: $6.90
Shares of Dakota Gold are soaring on an exchange upgrade.
The gold company rallied in today's premarket after news broke on Tuesday that its stock was being uplisted to the New York Stock Exchange's American exchange.
Widespread global conflict and a fracturing of the international monetary system resulting from Western sanctions has generated a buzz around gold lately, and the sentiment could be putting additional momentum behind the stock's push higher.
DC is up 48.6% on news of the upgrade.
Citius Pharmaceuticals [CTXR] - Last Close: $1.84
Citius Pharmaceuticals is up sharply after a promising clinical data release.
The specialty pharma firm reported topline results from Phase 3 trials of its antitumor I/ONTAK treatment for recurrent cutaneous T-cell lymphoma this morning, and the drug proved to be safe and effective.
Citius said it expects to file a biologics license application with the US Food & Drug Administration in the second half of the year, based on study data.
The firm's CEO, Myron Holubiak, said the results bring the company one step closer to launching its first commercial product next year if it's approved by the FDA.
CTXR is trading actively with an 18.5% gain.
